Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Blueprint Medicines Received FDA Orphan Drug Designation for Treatment of Mastocytosis

FDA
News

Blueprint Medicines Received FDA Orphan Drug Designation for Treatment of Mastocytosis

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=890922

byCharles Gross

July 1, 2022

1 minute read

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=890922

News

Why Vipshop Holdings Stock Hit A New 52-Week High Today

By Henry Khederian

June 8, 2:53 PM

Vipshop Holdings Ltd - ADR (NYSE: VIPS) shares are trading higher by 3.67% to $17.38 Thursday afternoon. Shares are seeing strength Thursday after multiple Chinese stocks fell Wednesday amid lackluster export data from China.

VIPS

DouYu International Hldgs Q4 Sales $243.70M Beat $241.59M Estimate

By Benzinga Newsdesk

March 20, 4:17 AM

DouYu International Hldgs (NASDAQ:DOYU) reported quarterly sales of $243.70 million which beat the analyst consensus estimate of $241.59 million by 0.87 percent. This is a 33.29 percent decrease over sales of $365.30

DOYU